en.wikipedia.org/wiki/Vivek_Ramaswamy

This appears to be outdated. In Vivek Ramaswamy's most recent Schedule 13G/A for Roivant Sciences Ltd., filed with the U.S. Securities and Exchange Commission on May 6, 2026, he reported beneficial ownership of 25,534,970 common shares, representing 3.6% of the class.

The filing explicitly states:

• "Aggregate Amount Beneficially Owned ... 25,534,970.00"
• "Percent of class represented by amount in row (9) 3.6 %"
• "Ownership totals disclosed do not include 13,357,857 shares held solely by Mr. Ramaswamy's spouse."

So the article's statement that he is "retaining a 7.17% stake" conflicts with the current SEC disclosure. Even if someone combined his spouse's separately held shares, that still would not match the article's exact 7.17% figure. The authoritative public filing shows 3.6%, not 7.17%.